| 25/06/21 | NattoPharma ASA : - Delisting | AQ |
| 15/06/21 | NattoPharma : Received application for delisting | AQ |
| 14/06/21 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 10/06/21 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 09/06/21 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 07/02/2018 |
Robert Schrama
DFI | Director of Finance/CFO | - | 08/03/2020 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 03/11/2004 |
| Director/Board Member | 52 | 31/01/2011 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 31/12/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| +0.92% | +6.80% | +77.57% | +129.14% | 1,109B | |
| +1.51% | +4.32% | +51.79% | +62.29% | 644B | |
| +1.55% | +6.65% | +27.00% | +77.18% | 463B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 371B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 301B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 256B | |
| +1.83% | +5.58% | +48.22% | +68.15% | 234B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 205B | |
| +2.21% | +6.02% | +26.30% | +93.17% | 178B | |
| Average | +1.48% | +3.00% | +31.55% | +53.51% | 417.9B | |
| Weighted average by Cap. | +1.24% | +3.26% | +44.75% | +73.09% |
Employees
18
Sector
Pharmaceuticals
